Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weili Sun

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Transplant Infectious Disease : an Official Journal of the Transplantation Society|August 30, 2020
Reactivation of human herpesvirus 6 in pediatric allogeneic hematopoietic stem cell transplant recipientsAnna B Pawlowska, Nicole A Karras, Huaying Liu, et al.
Immunity|May 18, 2024
Deficiency of CBL and CBLB ubiquitin ligases leads to hyper T follicular helper cell responses and lupus by reducing BCL6 degradationXin Li, Weili Sun, Mengxing Huang, et al.
EMBO Molecular Medicine|October 15, 2016
Am80-GCSF synergizes myeloid expansion and differentiation to generate functional neutrophils that reduce neutropenia-associated infection and mortalityLin Li, Xiaotian Qi, Weili Sun, et al.
Cancer|March 30, 2023
Detailed overview of incidence and management of cytokine release syndrome observed with teclistamab in the MajesTEC-1 study of patients with relapsed/refractory multiple myelomaThomas G Martin, Maria Victoria Mateos, Ajay Nooka, et al.
Blood|January 18, 2018
A phase 1 study of azacitidine combined with chemotherapy in childhood leukemia: a report from the TACL consortiumWeili Sun, Timothy Triche, Jemily Malvar, et al.
American Journal of Hematology|July 2, 2019
Association of leukemia genetics with response to venetoclax and hypomethylating agents in relapsed/refractory acute myeloid leukemiaIbrahim Aldoss, Dongyun Yang, Raju Pillai, et al.
Leukemia|February 26, 2020
Blinatumomab versus historical standard therapy in pediatric patients with relapsed/refractory Ph-negative B-cell precursor acute lymphoblastic leukemiaFranco Locatelli, James A Whitlock, Christina Peters, et al.
Pediatric Hematology and Oncology|April 28, 2020
A phase I study of panobinostat in children with relapsed and refractory hematologic malignanciesJohn Goldberg, Maria Luisa Sulis, Julia Bender, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 8, 2020
Pediatric Acute Lymphoblastic Leukemia, Version 2.2020, NCCN Clinical Practice Guidelines in OncologyPatrick Brown, Hiroto Inaba, Colleen Annesley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 2021
Apalutamide in Patients With Metastatic Castration-Sensitive Prostate Cancer: Final Survival Analysis of the Randomized, Double-Blind, Phase III TITAN StudyKim N Chi, Simon Chowdhury, Anders Bjartell, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Transplant Infectious Disease : an Official Journal of the Transplantation Society|August 30, 2020
Reactivation of human herpesvirus 6 in pediatric allogeneic hematopoietic stem cell transplant recipientsAnna B Pawlowska, Nicole A Karras, Huaying Liu, et al.
Immunity|May 18, 2024
Deficiency of CBL and CBLB ubiquitin ligases leads to hyper T follicular helper cell responses and lupus by reducing BCL6 degradationXin Li, Weili Sun, Mengxing Huang, et al.
EMBO Molecular Medicine|October 15, 2016
Am80-GCSF synergizes myeloid expansion and differentiation to generate functional neutrophils that reduce neutropenia-associated infection and mortalityLin Li, Xiaotian Qi, Weili Sun, et al.
Cancer|March 30, 2023
Detailed overview of incidence and management of cytokine release syndrome observed with teclistamab in the MajesTEC-1 study of patients with relapsed/refractory multiple myelomaThomas G Martin, Maria Victoria Mateos, Ajay Nooka, et al.
Blood|January 18, 2018
A phase 1 study of azacitidine combined with chemotherapy in childhood leukemia: a report from the TACL consortiumWeili Sun, Timothy Triche, Jemily Malvar, et al.
American Journal of Hematology|July 2, 2019
Association of leukemia genetics with response to venetoclax and hypomethylating agents in relapsed/refractory acute myeloid leukemiaIbrahim Aldoss, Dongyun Yang, Raju Pillai, et al.
Leukemia|February 26, 2020
Blinatumomab versus historical standard therapy in pediatric patients with relapsed/refractory Ph-negative B-cell precursor acute lymphoblastic leukemiaFranco Locatelli, James A Whitlock, Christina Peters, et al.
Pediatric Hematology and Oncology|April 28, 2020
A phase I study of panobinostat in children with relapsed and refractory hematologic malignanciesJohn Goldberg, Maria Luisa Sulis, Julia Bender, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 8, 2020
Pediatric Acute Lymphoblastic Leukemia, Version 2.2020, NCCN Clinical Practice Guidelines in OncologyPatrick Brown, Hiroto Inaba, Colleen Annesley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 2021
Apalutamide in Patients With Metastatic Castration-Sensitive Prostate Cancer: Final Survival Analysis of the Randomized, Double-Blind, Phase III TITAN StudyKim N Chi, Simon Chowdhury, Anders Bjartell, et al.
Pageof 8